Immunotec Announces Change in Marketing Management
07 March 2014 - 9:17AM
Marketwired
Immunotec Announces Change in Marketing Management
VAUDREUIL-DORION, QUEBEC--(Marketwired - Mar 6, 2014) -
Immunotec Inc. (TSX-VENTURE:IMM), a Canadian based company and a
leader in the wellness industry (the "Company") today announced
that Mr. Daniel Audet, Vice-President, Marketing, will be leaving
Immunotec effective March 11, 2014 to pursue new opportunities.
To enable smooth operational functioning and an orderly
evaluation of organizational needs, Ms. Kim Hayes will serve as
Senior Director of Marketing with accountability for all marketing
functions. Ms. Hayes will report to JP Trottier, Vice-President of
Field Development.
"Over the past three years, Mr. Audet and his team have made
significant contributions to advancing Immunotec's performance and
it is with appreciation that we wish all the best to Daniel in his
future endeavors", said Mr. Charles L. Orr, Chief Executive
Officer. "Ms. Hayes, as Director of Programs and Recognition, had
the lead responsibility for delivering the 2014 Convention in Santa
Fe, Mexico, 2013 Incentive Trip and 2013 Barbecue, all highly
successful activities. Ms. Hayes is a strong, knowledgeable leader
and I am certain that she will be able to make an immediate
positive impact on Immunotec's marketing activities."
About Immunotec Inc.
Immunotec Inc. is dedicated to making a positive difference in
people's lifestyle every day by offering research-driven
nutritional products through its network of Independent Consultants
worldwide. Immunotec's strength comes from its culture that
emphasizes teamwork and entrepreneurial leadership by employees,
consultants and research collaborators.
Headquartered with manufacturing facilities near Montreal,
Canada, Immunotec Consultants generate nearly $55.0 Million in
annual revenues. Please visit us at www.immunotec.com for
additional information.
The Company files its consolidated financial statements, its
management and discussion analysis report, its press releases and
such other required documents on the SEDAR database at
www.sedar.com and on the Company's website at www.immunotec.com.
The common shares of the Company are listed on the TSX Venture
Exchange under the ticker symbol IMM. Neither TSX Venture Exchange
nor its Regulation Services Provider (as that term is defined in
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
CAUTION REGARDING FORWARD-LOOKING STATEMENTS: Certain
statements contained in this news release are forward looking and
are subject to numerous risks and uncertainties, known and unknown.
For information identifying known risks and uncertainties and other
important factors that could cause actual results to differ
materially from those anticipated in the forward-looking
statements, please refer to the heading Risks and Uncertainties in
Immunotec's most recent Management's Discussion and Analysis, which
can be found at www.sedar.com. Consequently, actual results may
differ materially from the anticipated results expressed in these
forward-looking statements.
Patrick Montpetit CPA, CA, CFVice-President and Chief Financial
OfficerImmunotec Inc.(450) 510-4527
International Metals Min... (TSXV:IMM)
Historical Stock Chart
From Nov 2024 to Dec 2024
International Metals Min... (TSXV:IMM)
Historical Stock Chart
From Dec 2023 to Dec 2024
